Paper19086074
Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.
Girgenrath M and 4 others. Ann Neurol, 2009. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Papers, record 19086074. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19086074
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Doxycycline | Major topic |
| Laminin | Major topic |
| Muscular Dystrophy, Animal | Major topic |
| Age Factors | |
| Animals | |
| Apoptosis | |
| CD11b Antigen | |
| Cell Line, Transformed | |
| Disease Models, Animal | |
| Dose-Response Relationship, Drug | |
| Enzyme Inhibitors | |
| In Situ Nick-End Labeling | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Transgenic | |
| Motor Activity | |
| Muscle, Skeletal | |
| Mutation | |
| Phosphorylation | |
| Proto-Oncogene Proteins c-akt | |
| Staurosporine | |
| Survival Analysis | |
| Threonine |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AR049496 | NIAMS NIH HHS | United States | R01AR049496 | PubMed and NIH | NIH RePORTER |
| R01 HL064641 | NHLBI NIH HHS | United States | R01HL064641 | PubMed and NIH | NIH RePORTER |
| HL064641 | NHLBI NIH HHS | United States | R01HL064641 | PubMed and NIH | NIH RePORTER |
| AR049496 | NIAMS NIH HHS | United States | R01AR049496 | PubMed and NIH | NIH RePORTER |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16769901 | Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16769901 | PubMed |
| 2 | 12044978 | Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin alpha2-deficient mice. | J Neuroimmunol | 2002 | https://conductscience.org/library/papers/12044978 | PubMed |
| 3 | 10381357 | Activation of caspase-3 apoptotic pathways in skeletal muscle fibers in laminin alpha2-deficient mice. | Biochem Biophys Res Commun | 1999 | https://conductscience.org/library/papers/10381357 | PubMed |
| 4 | 16678816 | The AP-1 transcription factor regulates postnatal mammary gland development. | Dev Biol | 2006 | https://conductscience.org/library/papers/16678816 | PubMed |
| 5 | 12270689 | Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. | Neurobiol Dis | 2002 | https://conductscience.org/library/papers/12270689 | PubMed |
| 6 | 9326364 | Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. | FEBS Lett | 1997 | https://conductscience.org/library/papers/9326364 | PubMed |
| 7 | 15864313 | Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. | Nat Med | 2005 | https://conductscience.org/library/papers/15864313 | PubMed |
| 8 | 11565031 | An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. | Nature | 2001 | https://conductscience.org/library/papers/11565031 | PubMed |
| 9 | 10973608 | Differential phosphorylation at Ser473 and Thr308 of Akt-1 in rat brain following hypoglycemic coma. | Brain Res | 2000 | https://conductscience.org/library/papers/10973608 | PubMed |
| 10 | 16443056 | Tetracyclines: nonantibiotic properties and their clinical implications. | J Am Acad Dermatol | 2006 | https://conductscience.org/library/papers/16443056 | PubMed |
| 11 | 18071030 | Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial. | Arch Neurol | 2008 | https://conductscience.org/library/papers/18071030 | PubMed |
| 12 | 8655577 | Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. | J Cell Biol | 1996 | https://conductscience.org/library/papers/8655577 | PubMed |
| 13 | 15534092 | 7-hydroxystaurosporine (UCN-01) inhibition of Akt Thr308 but not Ser473 phosphorylation: a basis for decreased insulin-stimulated glucose transport. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15534092 | PubMed |
| 14 | 15569265 | Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. | J Neurochem | 2004 | https://conductscience.org/library/papers/15569265 | PubMed |
| 15 | 14625552 | Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. | Nat Genet | 2003 | https://conductscience.org/library/papers/14625552 | PubMed |
| 16 | 11297941 | IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. | Neuromuscul Disord | 2001 | https://conductscience.org/library/papers/11297941 | PubMed |
| 17 | 10679965 | Merosin and congenital muscular dystrophy. | Microsc Res Tech | 2000 | https://conductscience.org/library/papers/10679965 | PubMed |
| 18 | 17575261 | VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. | FASEB J | 2007 | https://conductscience.org/library/papers/17575261 | PubMed |
| 19 | 10616210 | Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency. | Lab Invest | 1999 | https://conductscience.org/library/papers/10616210 | PubMed |
| 20 | 11938437 | Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin). | Eur J Hum Genet | 2002 | https://conductscience.org/library/papers/11938437 | PubMed |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39064489 | Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39064489 | PubMed |
| 37388928 | Merosin-deficient congenital muscular dystrophy type 1a: detection of LAMA2 variants in Vietnamese patients. | Front Genet | 2023 | https://conductscience.org/library/papers/37388928 | PubMed |
| 37021539 | Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy. | Dis Model Mech | 2023 | https://conductscience.org/library/papers/37021539 | PubMed |
| 34568901 | Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy. | Hum Mol Genet | 2022 | https://conductscience.org/library/papers/34568901 | PubMed |
| 34290621 | Minocycline Treatment Reduces Mass and Force Output From Fast-Twitch Mouse Muscles and Inhibits Myosin Production in C2C12 Myotubes. | Front Physiol | 2021 | https://conductscience.org/library/papers/34290621 | PubMed |
| 33869655 | Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/33869655 | PubMed |
| 32591093 | Dermatomyositis Developed After Exposure to Epstein-Barr Virus Infection and Antibiotics Use. | Am J Med Sci | 2020 | https://conductscience.org/library/papers/32591093 | PubMed |
| 32457577 | A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD. | Front Mol Neurosci | 2020 | https://conductscience.org/library/papers/32457577 | PubMed |
| 32390798 | LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models. | Front Mol Neurosci | 2020 | https://conductscience.org/library/papers/32390798 | PubMed |
| 32197453 | Antioxidants Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/32197453 | PubMed |
| 31586140 | Early skeletal muscle pathology and disease progress in the dy3K/dy3K mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency. | Sci Rep | 2019 | https://conductscience.org/library/papers/31586140 | PubMed |
| 31308722 | Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy. | Appl Clin Genet | 2019 | https://conductscience.org/library/papers/31308722 | PubMed |
| 29772730 | At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy-Are We Closer to Effective Treatment for Patients? | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29772730 | PubMed |
| 29766020 | Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin. | Mol Ther Methods Clin Dev | 2018 | https://conductscience.org/library/papers/29766020 | PubMed |
| 29278895 | Aberrant Caspase Activation in Laminin-α2-Deficient Human Myogenic Cells is Mediated by p53 and Sirtuin Activity. | J Neuromuscul Dis | 2018 | https://conductscience.org/library/papers/29278895 | PubMed |
| 29191403 | Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. | Matrix Biol | 2018 | https://conductscience.org/library/papers/29191403 | PubMed |
| 28550268 | Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy. | J Neuromuscul Dis | 2017 | https://conductscience.org/library/papers/28550268 | PubMed |
| 28078067 | α-Linolenic Acid Reduces TNF-Induced Apoptosis in C2C12 Myoblasts by Regulating Expression of Apoptotic Proteins. | Eur J Transl Myol | 2016 | https://conductscience.org/library/papers/28078067 | PubMed |
| 27911334 | Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles. | J Neuromuscul Dis | 2016 | https://conductscience.org/library/papers/27911334 | PubMed |
| 27696112 | Laminin: loss-of-function studies. | Cell Mol Life Sci | 2017 | https://conductscience.org/library/papers/27696112 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ITGAM | 3684 | PubTator's text mining | https://conductscience.org/library/genes/3684 | NCBI Gene |
| LAMA2 | 3908 | PubTator's text mining | https://conductscience.org/library/genes/3908 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19086074
GET https://conductscience.org/api/papers/v1/19086074/references?page=2